Bausch Health Companies Inc. (BHC) News & Overview - Discounting Cash Flows
BHC
Bausch Health Companies Inc.
BHC (NYSE)

BHC's Business Model

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Sector & Industry Healthcare / Drug Manufacturers - Specialty & Generic
Website https://www.bauschhealth.com
CEO (Chief Executive Officer) Thomas J. Appio
Number of Employees
IPO date March 29, 1994

BHC Latest News

Contact
CountryCA
Address2150 St. ElzEar Boulevard West
CityLaval
StateQC
Phone15147446792
Zip CodeH7L 4A8
Other Identifiers
CIK0000885590
ISINCA0717341071
CUSIP071734107
Open7.12
Previous Close7.12
Volume1.18 Mil.
Average Volume2.58 Mil.
Day’s Range7.05 – 7.22
52 Week Range3.96-9.85
MA (50)5.2436
MA (200)6.9227
Market Cap2.61 Bil.
Shares Out.369.6 Mil.
Earnings DateJul 30, 2025
Beta
Last Dividend
EPS
PE

Industry Competitors for BHC

discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us